Functional macroautophagy induction by influenza A virus without a contribution to major histocompatibility complex class II-restricted presentation

Journal of Virology

Volumn 85, Issue 13, 2011, Pages 6453-6463

  Comber, Joseph D ^a   Robinson, Tara M ^a   Siciliano, Nicholas A ^a   Snook, Adam E ^a   Eisenlohr, Laurence C ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEASOME; HLA ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOPHAGOSOME; CD4+ T LYMPHOCYTE; CELL VACUOLE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; INFLUENZA; INFLUENZA VIRUS A; LYSOSOME; MACROAUTOPHAGY; MEMBRANE FUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; AUTOPHAGY; BAGG ALBINO MOUSE; FIBROBLAST; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H2N2; L CELL; METABOLISM; PATHOGENICITY; PHYSIOLOGY; VIROLOGY;

INFLUENZA A VIRUS; MUS; ORTHOMYXOVIRIDAE;

ANIMALS; ANTIGEN PRESENTATION; AUTOPHAGY; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; FIBROBLASTS; HISTOCOMPATIBILITY ANTIGENS CLASS II; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H2N2 SUBTYPE; L CELLS (CELL LINE); MICE; MICE, INBRED BALB C;

EID: 79960793780     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02122-10     Document Type: Article

References (73)

1. Blanchet, F., et al. 2010. Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses. Immunity 32:654-669.
2. Brazil, M., S. Weiss, and B. Stockinger. 1997. Excessive degradation of intracellular protein in macrophages prevents presentation in the context of major histocompatibility complex class II molecules. Eur. J. Immunol. 27: 1506-1514.
3. Chianese-Bullock, K. A., et al. 1998. Antigen processing of two H2-IEdrestricted epitopes is differentially influenced by the structural changes in a viral glycoprotein. J. Immunol. 161:1599-1607.
4. Crotzer, V., and J. Blum. 2008. Cytosol to lysosome transport of intracellular antigens during immune surveillance. Traffic 9:10-16.
5. Davis-Poynter, N., and H. Farrell. 1996. Masters of deception: a review of herpesvirus immune evasion strategies. Immunol. Cell Biol. 74:513-522.
6. Delamarre, L., R. Couture, I. Mellman, and E. S. Trombetta. 2006. Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis. J. Exp. Med. 203:2049-2055.
7. Delamarre, L., M. Pack, H. Chang, I. Mellman, and E. S. Trombetta. 2005. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 307:1630-1634.
8. Dengjel, J., et al. 2005. Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc. Natl. Acad. Sci. U. S. A. 102:7922-7927.
9. Dreux, M., and F. Chisari. 2009. Autophagy proteins promote hepatitis C virus replication. Autophagy 5:1224-1225.
10. Dreux, M., P. Gastaminza, S. F. Wieland, and F. V. Chisari. 2009. The autophagy machinery is required to initiate hepatitis C virus replication. Proc. Natl. Acad. Sci. U. S. A. 106:14046-14051.
11. Eisenlohr, L., W. Gerhard, and C. Hackett. 1988. Individual class II-restricted antigenic determinants of the same protein exhibit distinct kinetics of appearance and persistence on antigen-presenting cells. J. Immunol. 141: 2581-2584.
12. Eisenlohr, L., and C. Hackett. 1989. Class II major histocompatibility complex-restricted T cells specific for a virion structural protein that do not recognize exogenous influenza virus. Evidence that presentation of labile T cell determinants is favored by endogenous antigen synthesis. J. Exp. Med. 169:921-931.
13. Finley, D. 2009. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu. Rev. Biochem. 78:477-513.
14. Fuertes, G., J. Martin De Llano, A. Villarroya, A. Rivett, and E. Knecht. 2003. Changes in the proteolytic activities of proteasomes and lysosomes in human fibroblasts produced by serum withdrawal, amino-acid deprivation and confluent conditions. Biochem. J. 375:75-86.
15. Gannagé, M., et al. 2009. Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes. Cell Host Microbe 6:367-380.
16. Gannagé, M., and C. Munz. 2009. Autophagy in MHC class II presentation of endogenous antigens. Curr. Top. Microbiol. Immunol. 335:123-140.
17. Glickman, M. H., and A. Ciechanover. 2002. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82:373-428.
18. He, C., and D. Klionsky. 2009. Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet. 43:67-93.
19. Hennessy, K., and E. Kieff. 1983. One of two Epstein-Barr virus nuclear antigens contains a glycine-alanine copolymer domain. Proc. Natl. Acad. Sci. U. S. A. 80:5665-5669.
20. Hershko, A., and A. Ciechanover. 1998. The ubiquitin system. Annu. Rev. Biochem. 67:425-479.
21. Hurwitz, J., E. Herber-Katz, C. Hackett, and W. Gerhard. 1984. Characterization of the murine TH response to influenza virus hemagglutinin: evidence for three major specificities. J. Immunol. 133:3371-3377.
22. Jacobson, S., R. P. Sekaly, C. L. Jacobson, H. F. McFarland, and E. O. Long. 1989. HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells. J. Virol. 63:1756-1762.
23. Jagannath, C., et al. 2009. Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells. Nat. Med. 15: 267-276.
24. Jaraquemada, D., M. Marti, and E. Long. 1990. An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells. J. Exp. Med. 172:947-954.
25. Kabeya, Y., et al. 2000. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19:5720- 5728.
26. Kirkegaard, K. 2009. Subversion of the cellular autophagy pathway by viruses. Curr. Top. Microbiol. Immunol. 335:323-333.
27. Klionsky, D. 2007. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat. Rev. Mol. Cell Biol. 8:931-937.
28. Kopito, R. 2000. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 10:524-530.
29. Korolchuk, V., F. Menzies, and D. Rubinsztein. 2010. Mechanisms of crosstalk between the ubiquitin-proteasome and autophagy-lysosome systems. FEBS Lett. 584:1393-1398.
30. Kudchodkar, S., and B. Levine. 2009. Viruses and autophagy. Rev. Med. Virol. 19:359-378.
31. Kwun, H. J., et al. 2007. Kaposi's sarcoma-associated herpesvirus latencyassociated nuclear antigen 1 mimics epstein-barr virus EBNA1 immune evasion through central repeat domain effects on protein processing. J. Virol. 81:8225-8235.
32. Lamark, T., and T. Johansen. 2010. Autophagy: links with the proteasome. Curr. Opin. Cell Biol. 22:192-198.
33. Law, A., D. Lee, K. Yuen, M. Peiris, and A. Lau. 2010. Cellular response to influenza virus infection: a potential role for autophagy in CXCL10 and interferon-alpha induction. Cell Mol. Immunol. 7:263-270.
34. Lee, H., et al. 2010. In vivo requirement for Atg5 in antigen presentation by dendritic cells. Immunity 32:227-239.
35. Leung, C. S., T. A. Haigh, L. K. Mackay, A. B. Rickinson, and G. S. Taylor. 2010. Nuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 epitope display. Proc. Natl. Acad. Sci. U.S.A. 107:2165-2170.
36. Levitskaya, J., et al. 1995. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375:685- 688.
37. Levitskaya, J., A. Sharipo, A. Leonchiks, A. Ciechanover, and M. G. Masucci. 1997. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc. Natl. Acad. Sci. U. S. A. 94:12616-12621.
38. Lich, J. D., J. F. Elliott, and J. S. Blum. 2000. Cytoplasmic processing is a prerequisite for presenation of an endogenous antigen by major histocompatability complex class II proteins. J. Exp. Med. 191:1513-1524.
39. Loss, G. E., et al. 1993. Major histocompatibility complex class II-restricted presentation of an internally synthesized antigen displays cell-type variability and segregates from the exogenous class II and endogenous class I presentation pathways. J. Exp. Med. 178:73-85.
40. Luka, J., T. Lindahl, and G. Klein. 1978. Purification of the Epstein-Barr virus-determined nuclear antigen from Epstein-Barr virus-transformed human lymphoid cell lines. J. Virol. 27:604-611.
41. Mizushima, N., and T. Yoshimori. 2007. How to interpret LC3 immunoblotting. Autophagy 3:542-545.
42. Mizushima, N., A. Yamamoto, M. Matsui, T. Yoshimori, and Y. Ohsumi. 2004. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol. Biol. Cell 15:1101-1111.
43. Mortensen, M., et al. 2011. The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance. J. Exp. Med. 208:455-467.
44. Münz, C. 2009. Enhancing immunity through autophagy. Annu. Rev. Immunol. 27:423-449.
45. Nimmerjahn, F., et al. 2003. Major histocompatibility complex class IIrestricted presentation of a cytosolic antigen by autophagy. Eur. J. Immunol. 33:1250-1259.
46. Noda, N., Y. Ohsumi, and F. Inagaki. 2010. Atg8-family interacting motif crucial for selective autophagy. FEBS Lett. 584:1379-1385.
47. Noda, T., and Y. Ohsumi. 1998. Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast. J. Biol. Chem. 273:3963-3966.
48. Ogawa, M., and C. Sasakawa. 2006. Bacterial evasion of the autophagic defense system. Curr. Opin. Microbiol. 9:62-68.
49. Oxenius, A., et al. 1995. Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system. Eur. J. Immunol. 25:3402-3411.
50. Paludan, C., et al. 2005. Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 307:593-596.
51. Pankiv, S., et al. 2007. p62/SQSTM1 Binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 282:24131-24145.
52. Ravikumar, B., R. Duden, and D. C. Rubinsztein. 2002. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum. Mol. Genet. 11:1107-1117.
53. Riedel, A., et al. 2008. Endogenous presentation of a nuclear antigen on MHC class II by autophagy in the absence of CRM1-mediated nuclear export. Eur. J. Immunol. 38:2090-2095.
54. Rubin, D., M. Glickman, C. Larsen, S. Dhruvakumar, and D. Finley. 1998. Active site mutants in the six regulatory particle ATPases reveal multiple roles for ATP in the proteasome. EMBO J. 17:4909-4919.
55. Rubinsztein, D., et al. 2009. In search of an "autophagomometer". Autophagy 5:585-589.
56. Sanderson, S., and N. Shastri. 1994. LacZ inducible, antigen/MHC-specific T cell hybrids. Int. Immunol. 6:369-376.
57. Sant, A. 1994. Endogenous antigen presentation by MHC class II molecules. Immunol. Res. 13:253-267.
58. Savina, A., and S. Amigorena. 2007. Phagocytosis and antigen presentation in dendritic cells. Immunol. Rev. 219:143-156.
59. Savina, A., et al. 2006. NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 126:205-218.
60. Schmid, D., M. Pypaert, and C. Munz. 2007. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity 26:79-92.
61. Shvets, E., E. Fass, and Z. Elazar. 2008. Utilizing flow cytometry to monitor autophagy in living mammalian cells. Autophagy 4:621-628.
62. Sinnathamby, G., and L. C. Eisenlohr. 2003. Presentation by recycling MHC class II molecules of an influenza hemagglutinin-derived epitope that is revealed in the early endosome by acidification. J. Immunol. 170:3504-3513.
63. Sir, D., et al. 2008. Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response. Hepatology 48:1054-1061.
64. Tanida, I., et al. 2009. Knockdown of autophagy-related gene decreases the production of infectious hepatitis C virus particles. Autophagy 5:937-945.
65. Taylor, M. P., T. B. Burgon, K. Kirkegaard, and W. T. Jackson. 2009. Role of microtubules in extracellular release of poliovirus. J. Virol. 83:6599-6609.
66. Tewari, M., G. Sinnathamby, D. Rajagopal, and L. Eisenlohr. 2005. A cytosolic pathway for MHC class II-restricted antigen processing that is proteasome and TAP dependent. Nat. Immunol. 6:287-294.
67. van Luijn, M., et al. 2010. Alternative II-independent antigen-processing pathway in leukemic blasts involves TAP-dependent peptide loading of HLA class II complexes. Cancer Immunol. Immunother. 59:1825-1838.
68. Webb, J. L., B. Ravikumar, J. Atkins, J. N. Skepper, and D. C. Rubinsztein. 2003. α-Synuclein is degraded by both autophagy and the proteasome. J. Biol. Chem. 278:25009-25013.
69. Wileman, T. 2006. Aggresomes and autophagy generate sites for virus replication. Science 312:875-878.
70. Wing, S., H. Chiang, A. Goldberg, and J. Dice. 1991. Proteins containing peptide sequences related to Lys-Phe-Glu-Arg-Gln are selectively depleted in liver and heart, but not skeletal muscle, of fasted rats. Biochem. J. 275: 165-169.
71. Zaldumbide, A., M. Ossevoort, E. Wiertz, and R. Hoeben. 2007. In cis inhibition of antigen processing by the latency-associated nuclear antigen I of Kaposi sarcoma herpes virus. Mol. Immunol. 44:1352-1360.
72. Zhou, D., et al. 2005. Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens. Immunity 22:571-581.
73. Zhou, Z., et al. 2009. Autophagy is involved in influenza A virus replication. Autophagy 5:321-328.